NCT06280781 2026-03-30
IP9-ATLAS
Imperial College London
Phase NA Recruiting
Clinical Trials
3 trialsNCT03258593 2026-03-17
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT06238661 2026-03-05
ProScreenMRI
Fondazione del Piemonte per l'Oncologia
Phase NA Enrolling by invitation